You are here

  • Home
  • Archive
  • Volume 17, Issue 1
  • High-dose statin before percutaneous coronary intervention lowers risk of periprocedural myocardial infarction and 30-day major cardiac adverse events

Article Text

Article menu
Download PDFPDF
Therapeutics
Systematic review and meta-analysis
High-dose statin before percutaneous coronary intervention lowers risk of periprocedural myocardial infarction and 30-day major cardiac adverse events

https://doi.org/10.1136/ebm.2011.100057

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests Novartis Pharmaceuticals, American College of Cardiology Cardiosource